Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2/3 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Classical hematology 5Plasma cell 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Venous Thromboembolism 5Neoplasms 2Multiple Myeloma 2Urologic Neoplasms 1Urogenital Neoplasms 1Pulmonary Embolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Embolism 1

Interventions

apixaban 10Rivaroxaban 5Aspirin 4Enoxaparin 3abelacimab 2MAA868 2Heparin, Low-Molecular-Weight 2Dalteparin 2ribociclib 1palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1abemaciclib 1Rosuvastatin Calcium 1N(4)-oleylcytosine arabinoside 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Venous Thromboembolism × Rivaroxaban × 1 year × Clear all
NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting
1 enrolled
Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Ottawa Hospital Research Institute

Phase 2/3 Recruiting
120 enrolled
Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Recruiting
1,828 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡